Diethyldithiocarbamate modulation of murine bone marrow toxicity induced by cis-diammine(cyclobutanedicarboxylato)platinum (II).

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cancer Research

• Publication date

  1989-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 2555048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice.

  1989cited by this paper
• Biochemical modulation of cisplatin toxicity.

  1989cited by this paper
• Purification and characterization of mouse hematopoietic stem cells.

  1988cited by this paper
• Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.

  1988cited by this paper
• Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II).

  1988cited by this paper
• The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes.

  1987cited by this paper
• Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.

  1987cited by this paper
• 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.

  1987cited by this paper
• The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin.

  1987cited by this paper
• Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

  1986cited by this paper
• Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.

  1986cited by this paper
• Carboplatin: future directions.

  1985cited by this paper
• Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.

  1985cited by this paper
• Carboplatin: the clinical spectrum to date.

  1985cited by this paper
• Animal models for evaluating the myelosuppressive effects of cancer chemotherapeutic agents.

  1985cited by this paper
• The hemopoietic colony stimulating factors

  1984cited by this paper
• Drugs five years later. Cisplatin.

  1984cited by this paper
• Diethyldithiocarbamate and cis-Platinum Toxicity

  1984cited by this paper
• Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.

  1983cited by this paper
• Further evaluation of diethyldithiocarbamate as an antagonist of cisplatin toxicity.

  1982influential reference
• Cisplatin

  1982cited by this paper
• Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.

  1979cited by this paper
• The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y).

  1968cited by this paper
• A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

  1961cited by this paper
• A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

  1956cited by this paper
• Phosphorus compounds in animal tissues; extraction and estimation of desoxypentose nucleic acid and of pentose nucleic acid.

  1945cited by this paper

• Advances in anticancer applications of platinum(II) complexes of dithiocarbamates

  2024cites this paper
• Phosphanegold(I) dithiocarbamates, R3PAu[SC(=S)N((i)Pr)CH2CH2OH] for R = Ph, Cy and Et: role of phosphane-bound R substituents upon in vitro cytotoxicity against MCF-7R breast cancer cells and cell death pathways.

  2013cites this paper
• Pharmacokinetics of erythropoiesis-stimulating agents

  2009cites this paper
• Pharmacodynamic model for chemotherapy-induced anemia in rats

  2008cites this paper
• Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes.

  2007cites this paper
• Kinetics of the thermal decomposition of diethyldithiocarbamato tellurium (IV)

  2006cites this paper
• Diethyldithiocarbamate chemoprotection of carboplatin-induced hematological toxicity

  2005cites this paper
• The importance of schedule on diethyldithiocarbamate modulation of drug-induced myelosuppression

  2004cites this paper
• Cytotoxicity Profiles for a Series of Triorganophosphinegold(I) Dithiocarbamates and Triorganophosphinegold(I) Xanthates

  2004cites this paper
• WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach

  2004cites this paper
• Chemoprotective effect of Ixora coccinea L. flowers on cisplatin induced toxicity in mice

  2001cites this paper
• Bone marrow stem cell protection from chemotherapy by low--molecular-weight compounds.

  2001cites this paper
• Hematopoietic stem and progenitor cells as targets for biological reactive intermediates.

  2001cites this paper
• Dithiocarbamates inhibit hematopoiesis via a copper-dependent mechanism.

  2000cites this paper
• Platinum(II) complexes with 1-amino-4-thiapentylphosphonic acid and its diethyl ester

  1999cites this paper
• Cisplatin inhibits protein synthesis in rabbit reticulocyte lysate by causing an arrest in elongation.

  1997cites this paper
• Self-assembling drugs: a new approach to biochemical modulation in cancer chemotherapy.

  1994cites this paper
• Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

  1993cites this paper
• Synthesis, characterization and evaluation of biological activity of palladium (II) and platinum (II) complexes with dithiocarbamic acids and their derivatives as ligands

  1993cites this paper
• Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons.

  1992cites this paper
• Transcriptional regulation of cytokine expression by diethyldithiocarbamate in human HL-60 promyelocytic leukemia cells.

  1992cites this paper
• Disulfiram and its Metabolite, Diethyldithiocarbamate

  1992cites this paper
• Synthesis, characterization, cytotoxicity and DNA binding studies of diamminediethyldithiocarbamato-platinum(II) nitrate.

  1992cites this paper
• Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.

  1992cites this paper
• Diethyldithiocarbamate induction of cytokine release in human long-term bone marrow cultures.

  1992cites this paper
• Alterations in the growth and cycling status of granulocyte-monocyte colony-forming units (CFU-GM) in rats injected single doses of aflatoxin B1.

  1992cites this paper
• Clinical Pharmacokinetics of Carboplatin

  1991cites this paper
• The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.

  1991cites this paper
• Diethyldithiocarbamate, copper and neurological disorders.

  1991cites this paper
• Effects of diethyldithiocarbamate (DDTC) on the plasma biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in Fischer 344 rats.

  1991cites this paper
• Clinical pharmacokinetics of carboplatin.

  1991cites this paper
• Mechanism of diethyldithiocarbamate modulation of murine bone marrow toxicity.

  1990cites this paper
• Modification of cisplatin toxicity with diethyldithiocarbamate.

  1990cites this paper
• Drug-induced DNA damage and tumor chemosensitivity.

  1990cites this paper